Member Info for KaChing

Another 5.4m mopped up, when they stop buying they will let it go ..... that's what is normally said when trying to be rampy

Moving in the right direction, 135% increase in revenue and the start of this year is already 100%+ up on the same period last year. They are still looking for bolt on acquisitions ……. FCF still a way off but there is a nice cash balance to fall back on and hopefully Innovenn should start to contribute to revenue etc this year. Back to sleep.

are now being held by longer term (hopefully) investors after Gate mopped up yet more shares

for this free cash yielding company "2015 was a transformative year for the business during which the Company was restructured and a new base was established for developing the business. I am glad to be able to report that the Company has had an excellent start to the new financial year, with trading in line with management expectations in Q1, and our results for 2015 are in line with market expectations, as previously confirmed."

and we will be offered a chance to buy in an open offer, good to know they still have cash of £800k which should mean the placing will be used for it's intended purpose as opposed to being needed for working cap.

nice, the value was always there in the background, lets see what the rest of the market thinks

It looks a great acquisition, the balance sheet of QRO looks very healthy, going back over the last 5 years they have grown net assets (shareholder funds) steadily from £455k to £683k in 2015 Cash generation looks very impressive leaving them consistently with around £900k+ at the end of the last 4 financial years (5 years back cash was £550k). Now that cash pile is sitting on the PEG balance sheet …… the acquisition is almost paying for itself!! Above info from Companies House.

That was a pleasant couple of RNS’s, very bullish AGM statement and the acquisition costing around £572k after factoring in the net asset value of the acquisition which also has £876k in cash on the balance sheet. More of the same please along with conversion of contracts under negotiation.

It looks like there really might be some movement, another decent contract or earnings enhancing acquisition would go down very nicely now. Back to sleep

That's more hoovered up

http://www.irishtimes.com/business/health-pharma/revenue-at-clinical-trials-group-venn-will-be-significantly-over-10m-1.2586313

ticking along nicely ....... ahead of expectations, free cash flow etc. etc Back to sleep.

That reads very well.

It looks like the cash pile will go towards making the company bigger through acquisition, it will be interesting to see what they are reviewing at the moment, anything earnings enhancing as long as they don't over pay would be preferable to buy backs, for me anyway. "We intend to expand the Group into a larger and more prosperous business. The board has under review a number of potential businesses to acquire and we will of course be keeping shareholders fully advised of our progress."

Free cash flow for the full year of just over £1m which has boosted the cash pile to an undiluted 7p per share which is over half the current share price, impressive!

So the company that bought the 15mw development are now interested in what Rame have on their books, that's a positive, the announcement only evens out last years announcement regarding Chrome that has now terminated, not sure about that. Presumably the cash from the 15mw sale is already in the bank.

Has arrived

Probably because the vast majority of the revenue figure won't show up until year 3 .....

Full year results out in two weeks time, maybe they’ll show a profit of around £1m (EPS of 2.8p) for the year and a cash pile growing to an equivalent of about 6.5p per share ……. and now the capital reduction thingy is out of the way I’m hoping we see some of that cash pile in the form of a dividend.

Still cheap ....... well, I would say that.